PRagmatic Study Of Messaging to Providers of Patients With Heart Failure in Amsterdam UMC
Recruiting · NCT06344910 · Observational (researchers observe without assigning treatment) · Lead sponsor: Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)
View the official record on ClinicalTrials.gov →Interventions studied
Best practice alert for the notification of patients with HFrEF and recommended evidence-based therapies
What this trial is about
This is a prospective cohort study, where the investigators aim to investigate the effect of implementation of an electronic nudge alerting clinicians to the prescription of the 4 key pharmacological classes for the treatment of patients with heart failure and reduced ejection fraction (HFrEF) at the outpatient clinic in the Netherlands.
Who can take part
Age range
18 Years and older
Sex
All (male and female)
Healthy volunteers
No - a diagnosis or condition is required
Phase
Not specified
Study type
Observational (researchers observe without assigning treatment)
Inclusion criteria
- Age \> 18 years
- Treatment for HFrEF at the outpatient clinic cardiology.
- Documented reduced ejection fraction of \<40% based on cardiac ultrasound or cardiac magnetic resonance imaging.
Exclusion criteria
- Opt-out for the use of routine clinical data for research purposes
Where it is running
2 locations listed.
- Amsterdam University Medical Centers, Location AMC - Amsterdam, Netherlands
- Amsterdam University Medical Centers, Location VU Medical Center - Amsterdam, Netherlands